Biogen sues Pharmacor over patent for MS drug Tecfidera
Ben Mee 2021-08-10 5:02 pm By Miklos Bolza | Sydney
Please login to bookmark Close

Swiss pharmaceutical company Biogen has filed another lawsuit accusing an Australian generic drug manufacturer of infringing the patent for its blockbuster multiple sclerosis drug Tecfidera.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au